Biological Evaluation of Therapeutics Engineered with De Novo Designed Miniproteins
Time: 10:00 am
day: Conference Day Two
Details:
- Engineering multivalent miniprotein immune cell engagers to design optimal immune synapses
- Designing and validating biological strategies to assess ligand-receptor interactions with miniproteins
- Evaluating pharmacokinetics parameters of miniprotein to engineer therapeutic products
